[Prevention of graft rejection and disease recurrence with cyclosporin A in keratitis of Whitaker's syndrome].
Manderieux
N
N
Hôpital Laennec, Paris.
Putterman
M
M
Brauner
R
R
De Prost
Y
Y
Gral
C
C
Dufier
J L
JL
Haye
C
C
D000293:Adolescent; D003524:Cyclosporins / Q000627:therapeutic use*; D004700:Endocrine System Diseases / Q000150:complications / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D007634:Keratitis / Q000209:etiology / Q000628:therapy*; D012008:Recurrence; D013577:Syndrome
D003524:Cyclosporins
Prévention du rejet de greffe et de la récidive de la maladie par la ciclosporine A dans la kératite du syndrome de Whitaker.